DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behavioral health coaching for stress, anxiety and loneliness, conditions which have recently escalated due to COVID-19 social distancing restrictions including "shelter-in-place" and "stay-at-home" orders.
DarioHealth currently has over 51,000 active paying users, most of which have underlying conditions that increase the risk of severe COVID-19 complications.
"Loneliness among Americans had already increased from approximately 50% of Americans to approximately 60% over the last two years, prior to the Coronavirus outbreak," said Omar Manejwala, M.D., chief medical officer of DarioHealth. "These conditions are often aggravated by unemployment, disease exacerbation, grief, bereavement and fear surrounding a global crisis. Loneliness, stress and anxiety have a known direct impact on chronic disease outcomes, and we wanted to expand our current evidence-based coaching approaches to include additional support for behavioral health conditions. We believe that implementing these changes will lead to better, more comprehensive care for all Dario users."
Recent moves by the Food and Drug Administration (the "FDA") have provided digital health companies an opportunity to be more actively involved as states, countries and continents look for new solutions to combat the COVID-19 pandemic. In that regard, the FDA eased several requirements for the use of low risk digital tools for mental health recently.
"We continue to evolve, improve and expand our platform with the goal of delivering a more robust menu of clinically meaningful services to our members. We believe that the results of the expansion of our platform reflect a more complete solution for remote care in between physician office visits and improved health. We believe that our active dialogue with our members speaks to the high level of engagement and trust, and why we have earned a +77 Net Promoter Score and a 4.9 user rating on the AppStore," said Richard Anderson, president and general manager of North America of DarioHealth.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital health company serving its users with dynamic mobile health solutions. In today's day and age, knowledge of health and treatment is being democratized, and we believe people deserve to know everything about their own health and have the best tools to manage their condition. DarioHealth employs a revolutionary approach whereby harnessing big data, we have developed a novel method for chronic disease data management, empowering people to analyze and personalize chronic disease management in a totally new way without having their conditions slow them down. DarioHealth has a commercial office in New York, New York with an R&D center in Caesarea, Israel.
